Lack of interaction between valaciclovir, the L-valyl ester of acyclovir, and Maalox antacid. 1996

F de Bony, and R Bidault, and R Peck, and J Posner
Department of Clinical Pharmacology, Laboratoires Wellcome, Issy les Moulineaux, France.

Valaciclovir is rapidly and extensively converted to acyclovir. In this study we investigated the potential interaction between oral valaciclovir and Maalox. On each of three occasions 18 healthy volunteers received a single oral dose of 1000 mg valaciclovir, or 30 mL Maalox 65 min after valaciclovir administration, or 30 mL Maalox 30 min before valaciclovir. Acyclovir plasma concentrations and pharmacokinetic parameters were not significantly affected by administration of Maalox before or after valaciclovir. Therefore, there is no need for restriction of valaciclovir dosing in patients receiving antacid medication.

UI MeSH Term Description Entries
D008276 Magnesium Hydroxide An inorganic compound that occurs in nature as the mineral brucite. It acts as an antacid with cathartic effects. Brucite,Magnesium Hydrate,Magnesium Hydroxide (Mg(OH)4),Hydrate, Magnesium,Hydroxide, Magnesium
D008297 Male Males
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077483 Valacyclovir A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES. 2-((2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl L-valinate,256U87,Acyclovir, L-valyl Ester,BW256U87,L-Valylacyclovir,Valaciclovir,Valacyclovir Hydrochloride,Valacyclovir Hydrochloride, (DL)-isomer,Valacyclovir, (D)-isomer,Valacyclovir, (DL)-isomer,Valacyclovir, (L)-isomer,Valacyclovir, D-,Valacyclovir, X-Hydrochloride, (D)-isomer,Valacyclovir, X-Hydrochloride, (DL)-isomer,Valtrex,Acyclovir, L valyl Ester,D- Valacyclovir,L Valylacyclovir,L-valyl Ester Acyclovir
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U

Related Publications

F de Bony, and R Bidault, and R Peck, and J Posner
January 1993, Journal of medical virology,
F de Bony, and R Bidault, and R Peck, and J Posner
January 1998, British journal of clinical pharmacology,
F de Bony, and R Bidault, and R Peck, and J Posner
January 1996, Current problems in dermatology,
F de Bony, and R Bidault, and R Peck, and J Posner
June 1995, The Journal of biological chemistry,
F de Bony, and R Bidault, and R Peck, and J Posner
December 1995, Antimicrobial agents and chemotherapy,
F de Bony, and R Bidault, and R Peck, and J Posner
July 1994, Antimicrobial agents and chemotherapy,
F de Bony, and R Bidault, and R Peck, and J Posner
January 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
F de Bony, and R Bidault, and R Peck, and J Posner
August 2002, Pharmaceutical research,
F de Bony, and R Bidault, and R Peck, and J Posner
January 2006, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!